PGY2 pharmacy residency programs build on the Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advanced or specialized practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacy and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists). This program focuses on the development and advancement of ambulatory services and disease state management in a complex and underserved population, while acquiring scholarly and academic experiences to prepare for a career in ambulatory care and academia.

The Oregon State University (OSU) PGY2 ambulatory care residency is offered in collaboration with Oregon Health Science University (OHSU) Family Medicine at Richmond (FMR). Richmond is a Federally Qualified Health Center (FQHC) and level 3 Patient Centered Primary Care Home. This is a 12 month program designed to develop expertise in ambulatory care disease state management in a complex and underserved population of Portland, OR. Rotations are longitudinal in nature. The resident will work under collaborative drug therapy management (CDTM) agreements and provide direct patient care visits. Current CDTM agreements include tobacco cessation, type 2 diabetes, hypertension, hepatitis C, and chronic obstructive pulmonary disease (COPD). Residents will also collaborate with primary care providers, nurses, behavioral health and other clinical staff. Residents will have the opportunity to develop and implement a new clinical service for Richmond to further enhance patient care.

Teaching Activities

PGY2 residents have the opportunity to participate in case facilitation in the pharmacy practice course and selected lectures in the integrated drug therapy course with third-year pharmacy students. Opportunities for experiential precepting of fourth year students throughout their ambulatory care rotation are also available.


Residents are required to complete one major project within the clinic. Data gathered from the project will be presented with an ASHP Midyear Meeting poster and written in a publishable manuscript. Residents are also given the opportunity to partner with college faculty members to complete various academia-focused projects.

Residents are also required to work with the Drug Use Research and Management (DURM) team. The DURM team is a partnership between Oregon State University College of Pharmacy and the state Oregon Pharmacy & Therapeutics Committee. The resident will be expected to prepare an editorial newsletter, as well as a medication utilization evaluation (MUE) on assigned topics.

Other Position Information

Program ID: 94032 NMS Code: 747465

Number of Positions: 1

Application Deadline: 1/04/2021

Starting Date: 7/05/2021


Estimated Stipend: $50,000

Fringe Benefits: Benefits include 10 personal leave days (including sick days); 9 observed holidays; and Medical, Dental, and Vision coverage


Special Requirements for Acceptance:

ASHP-accredited PGY-1 residency; eligible for licensure in Oregon; 3 letters of recommendations; letter of intent; Curriculum Vitae.

Additional Information:

The start date of the residency program will be the Monday following the 4th of July. Upon starting, there will be a three week orientation experience both at the clinic and the college of pharmacy.

Monday Tuesday Wednesday Thursday Friday Saturday Sunday
Clinic Clinic Clinic



College of


Free, Staffing in

FMR Outpatient

Pharmacy one

Saturday per



Residency Information: AHSP

During the longitudinal family medicine rotation, the resident will work under collaborative practice agreements to provide chronic disease management to their panel of patients. They will also serve as the drug information specialist while collaborating with an interprofessional health care team and participate in transitions of care for high risk patients. Elective experiences are available based on the resident’s interests including, but not limited to, geriatrics and medication assisted therapy (MAT) and addiction.

OSU/OHSU will be offering an informal information sessions over Zoom to allow for potential candidates a platform to ask questions prior to submitting applications. Applicants are encouraged to join the session at any time during the available times. There will be a brief overview of the program every 30 minutes followed by an open question and answer forum.

Session 1: 12/16/2020 from 3:00PM to 5:00PM PST. To join session click here

Session 2: 12/21/2020 from 4:30PM to 6:30PM PST. To join session click here



Additionally, we will have scheduled time slots for one-on-one information sessions for potential applicants. Please schedule an available time slot using the following link to learn more about the program.


For any additional information, please contact
Megan Viehmann, PharmD, BCACP
Residency Program Director, Pharmacy Manager


Jenn Stanislaw, PharmD, BCACP
Preceptor, OSU Clinical Faculty

Current Resident:

Rebekah Bartholomew, PharmD



Why I chose OSU/OHSU Family Medicine at Richmond:

Due to my interest in pursuing academia after residency training, I focused on choosing a PGY2 program that could meet my needs to learn more about ambulatory care and academia simultaneously. This program met those needs and more by also allowing me to care for underserved populations, especially patients from both racial and gender identity minorities. OSU and OHSU Family Medicine at Richmond clearly demonstrated to me a commitment to always put patient care first, to work collaboratively and inter-professionally, and to have fun while doing so.



Residency Program Director:

Megan Viehmann, PharmD, BCACP